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PURPOSE: To report the experience of a radiology department in the use of computed tomography – guided cutting needle
biopsy of pulmonary nodules, by evaluating diagnostic yield and incidence of complications.
METHODS: This is a retrospective analysis of 52 consecutive patients who underwent lung lesion biopsy guided by computed
tomography, performed between May 1997 and May 2000. Thirty-five patients were male and 17 were female, with ages ranging
from 5 to 85 years (median, 62 years). The size of the lesions ranged from 1.8 to 15 cm (median, 5.4 cm).
RESULTS: In a total of 52 biopsies of lung lesions, 51 biopsies (98.1%) supplied appropriate material for histopathological
diagnosis, with 9 diagnosed (17.3%) as benign and 42 (80.8%) as malignant lesions. Specific diagnosis was obtained in 44 (84.6%)
biopsies: 4 benign (9.1%) and 40 (90.9%) malignant lesions. The sensitivity, specificity, and accuracy of the cutting needle biopsies
for determining presence of malignancy were 96.8%, 100%, and 97.2%, respectively. Complications occurred in 9 cases (17.3%),
including 6 cases (11.5%) of small pneumothorax, 1 (1.9%) of hemoptysis, 1 (1.9%) of pulmonary hematoma, and 1 (1.9%) of
thoracic wall hematoma. All had spontaneous resolution. There were no complications requiring subsequent intervention.
CONCLUSION: The high sensitivity and specificity of the method and the low rate of complications have established cutting
needle biopsy as an efficient and safe tool for the diagnosis of lung lesions. In our hospital, cutting needle biopsy is considered a
reliable procedure for the evaluation of indeterminate pulmonary nodules.
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The use of computed tomography
(CT)–guided fine-needle aspiration bi-
opsy has been widely used with high
accuracy as reported for diagnosis of
lung lesions, especially carcinomas1.
On the other hand, for non-carcinoma-
tous lesions, the accuracy of the
method is inferior, reported in the
range of 46% to 68%2-4. Difficulties in
diagnosing benign lesions and the una-
vailability of a cytopathologist in the
radiology department have mandated
the need to perform biopsies that could
supply material for histological analy-
sis. Several successful experiences with
core biopsy using automated cutting
needles in several solid organs3 encour-
aged the use of the same method in
lung lesions5-8. Previous studies re-
ported sensitivity, specificity, and com-
plication rate of this procedure5-8. All
authors concurred that this technique
produces appropriate material for diag-
nosis with a high accuracy rate and ac-
ceptable incidence of complications5-8.
Despite being a well-established
method, the application of CT-guided
needle biopsy among radiologists in
our country is still not common. Few
national studies have reported transtho-
racic biopsy experience, and no spe-
cific emphasis has been made regard-
ing the cutting needle9-10. The objective
of the present study is to present the
initial experience of a radiology depart-
ment in the use of the cutting needle
biopsy of pulmonary nodules, by
evaluating diagnostic yield and inci-
dence of complications.
MATERIALS AND METHODS
This report is a retrospective analy-
sis of 52 consecutive patients who un-
derwent lung lesion biopsy guided by
CT using a cutting needle, performed
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between May 1997 and May 2000.
Written informed consent was obtained
from all patients. Thirty-five patients
were male and 17 were female, with
ages ranging from 5 to 85 years (me-
dian, 62 years). The size of the 52 lung
lesions ranged from 1.8 to 15 cm (me-
dian, 5.4 cm).
We used a CT Pace (GE-General
Electric) scanner to locate the lesion
and to guide the needle introduction.
Patients were positioned to allow more
direct access to the lesion, minimizing
passage by aerated lung tissue to re-
duce the risk of pneumothorax. The
needle introduction site was selected
and localized on the patient by placing
an external metallic marker. An auto-
mated 18-gauge cutting needle (MD
Tech Tru-Core®) was used in 40 cases,
and an automated coaxial 20-gauge
cutting needle with a 19-gauge intro-
ductory cannula system (Temno Bi-
opsy needle and introductory cannula)
was used in 12 cases. Local anesthesia
with 1% lidocaine was applied from
the skin to the pleura following the
planned biopsy pathway. The needle
was then introduced with the patient in
expiratory apnea, and new CT scans
were obtained to check the position of
the needle in relation to the lesion.
When the 18-gauge needle was used,
it was introduced directly into the le-
sion. The automatic gun was then con-
nected and fired to advance the needle
cutting edge for 13 or 20 mm, depend-
ing on the lesion size. With the coaxial
system, the introducer stylet–outer can-
nula combination was positioned at the
margin of the lesion and confirmed
with CT scans. The introducer stylet
was removed from the outer cannula,
and the cutting needle was inserted into
the outer cannula and fired, with an
advance of 20 mm of the needle’s cut-
ting edge. The biopsy site could be
visualized by CT control. In both situ-
ations, the procedure was repeated until
the samples were macroscopically ap-
propriate or pneumothorax was
present. The fragments were preserved
in 10% formalin and submitted for his-
topathological examination by staff of
the pathology department of our insti-
tution.
After the biopsy, all patients had
control CT scans to evaluate for pres-
ence of complications.
RESULTS
In a total of 52 biopsies of lung le-
sions, 51 biopsies (98.1%) supplied
appropriate material for histopathologi-
cal diagnosis, with 9 diagnosed
(17.3%) as benign lesions and 42
(80.8%) as malignant. Specific diagno-
sis was obtained in 44 (84.6%) biop-
sies: 4 benign (9.1%) and 40 (90.9%)
malignant lesions (Table 1).
In the group of malignant lesions,
there were 26 bronchogenic carcino-
mas, 11 metastases, 2 cases of lym-
phoma, 1 mesothelioma, and 2 cases
with malignant diagnosis of no speci-
fied type. Among the bronchogenic
carcinomas, 20 cases were non-small
cell carcinomas (8 cases of adenocar-
cinoma and 12 cases of squamous cell
carcinoma), 2 cases were small cell
carcinomas, and in 4 cases the carci-
noma type was not specified. Eleven
metastatic lesions including 9 carcino-
mas, 1 fibrosarcoma, and 1 osteosar-
coma were identified (Table 2).
Diagnostic confirmation was possi-
ble in 36 cases, by surgery in 9, and by
clinical follow-up in 27 cases. In these
patients, the diagnoses provided by bi-
opsy were considered as definitive, and
a therapeutic regimen was established.
In malignant cases, the patients under-
went chemotherapy or radiotherapy.
Two benign cases were confirmed
clinically; one case with chronic in-
flammation had complete radiological
image resolution, and the other case
with fibrosis had radiological image
stability and was clinically asympto-
matic for 2 years. The definitive diag-
noses included 31 (86.1%) malignan-
cies and 5 (13.9%) of benign disease
(Table 2). In 15 cases, diagnostic con-
firmation was not possible because
these patients were no longer being
treated at our institution.
From the 5 cases of benign lesions
without specific diagnosis on needle
biopsy, definitive histology was ob-
tained by surgery in 4: 1 granuloma, 1
inflammatory pseudotumor, 1 neurofi-
broma, and 1 adenocarcinoma.
The 2 malignant lesions without
specific diagnosis on needle biopsy
were confirmed as Hodgkin’s lym-
phoma by surgical biopsy and as meta-
static osteosarcoma by clinical follow-up.
Utilizing surgical biopsy or clinical
follow-up as a gold standard to calcu-
late the sensitivity and specificity of
needle biopsy for determining the pres-
ence of malignancy in a total of 36
cases, we obtained a sensitivity of
96.8%, a specificity of 100%, and an
accuracy of 97.2% (Table 3).
In a total of 52 biopsies of lung le-
sions, complications occurred in 9
(17.3%)—4 after using an automated
18-gauge cutting needle (MD Tech Tru-
Core) and 5 after using an automated
coaxial 20-gauge cutting needle (Temno
Biopsy needle and introductory can-
nula). Six cases (11.5%) of small pneu-
mothorax that did not require drainage,
1 (1.9%) of hemoptysis, 1 (1.9%) of
Table 1 - Results of core biopsy of 52 lung lesions.
No. Cases Specific diagnosis
Adequate sample 51 (98.1%)
Benign 9 (17.3%) 4 (9.1%)
Malignant 42 (80.8%) 40 (90.9%)

REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(1):15-18, 2002JANUARY-FEBRUARY
pulmonary hematoma, and 1 (1.9%) of
thoracic wall hematoma were docu-
mented. All had spontaneous resolution.
There were no complications requiring
subsequent intervention.
DISCUSSION
Despite the popularity of automated
systems for obtaining tissue samples in
several solid organs3, their use in lung
lesions has been very restricted in our
country. Previous studies have demon-
strated the advantage of the diagnostic
yield of the cutting needle biopsy, with
acceptable incidence of complications,
when compared to fine-needle aspira-
tion biopsy. Coaxial needles have the
advantage of using a smaller gauge in-
troductory cannula, allowing many
passages of the cutting needle after its
placement. In the present study, the
supply of coaxial systems was not con-
stant, and Tru-Core cutting needles
were used as substitutes. Our study
demonstrated that cutting needles, ei-
ther with or without a coaxial system,
provided appropriate pathology mate-
rial (98.1%) for histological analysis
and diagnosis, with an accuracy of
97.2%, a sensitivity of 96.8%, and a
specificity of 100% in identifying ma-
lignant lesions. These values are com-
parable to the results found in previous
papers, with reported accuracy ranging
from 80% to 95%5-8, sensitivity from
93% to 95%5-6,8, and specificity of
100% for malignant lesions6,8. The high
rate of adequate samples (98.1%) prob-
ably results from the use of automated
systems that provide standardized  col-
lection of the material, which are less
operator-dependent in comparison with
fine-needle aspiration biopsies that
supply appropriate samples varying
from 16% to 94% of time6,9. The spe-
cific diagnosis rate (84.6%) is also
greater than reported in the literature
for fine-needle aspiration biopsies
(39% to 77%4-5), eliminating the need
for the presence of a cytopathologist
during the biopsy procedure.
The number of complications was
small (17.3%), and all cases had good
outcome, demonstrating the safety of
the method. The incidence of pneumot-
horax reported in the literature varies
from 9% to 54% for biopsies using au-
tomated systems5-7, which is similar to
findings in our study (11.4%). No chest
tube placement was needed in our pa-
tients, while the rate of thoracic drain-
age varied from 2% to 18% in the pre-
vious studies5-6. This result could be
explained by the selection of different
types of needles for lesions with differ-
ent sizes and locations. Although the
distance analysis between the lesion
and the thoracic wall was not possible
for all cases, there was a trend, in
agreement with the literature, of using
18-gauge cutting needles for larger and
more outlying lesions and 20-gauge
needles with coaxial system for smaller
and deeper lesions.
The high sensitivity and specificity
of the method and low rate of compli-
cations have established the cutting
needle biopsy as an efficient and safe
tool for diagnosis of lung lesions. In
our hospital, cutting needle biopsy is
considered a reliable procedure for the
evaluation of indeterminate pulmonary
nodules.
Table 2 - Specific diagnosis of 51 core biopsies of lung lesions and definitive
diagnoses of 36 cases confirmed by surgery or clinical follow-up.
Diagnosis Number of lesions Definitive diagnoses Confirmation criteria
Malignant lesions 42 31 25 clinically/6 surgery
Bronchogenic carcinomas 26 18
Non-small cell 20 16 13 clinically/3 surgery
Small cell 2 2 2 clinically
Not specified 4
Metastatic disease 11 9
Carcinoma 9 6 5 clinically/1 surgery
Sarcoma 2 3 3 clinically
Lymphoma 2 3 1 clinically/2 surgery
Mesothelioma 1 1 clinically
Not specified 2
Benign lesions 9 5 2 clinically/3 surgery
Hamartoma 1 0 No confirmation of diagnosis
Chronic inflammation 1 1 Radiological image resolution
Fibrosis 2 1 Radiological image
stability for 2 years
Granuloma (tuberculosis) 0 1 surgery
Inflammatory pseudotumor 0 1 surgery
Neurofibroma 0 1 surgery
Not specified 5
Table 3 - Needle biopsy versus surgical/
clinical diagnosis.
Surgical or clinical diagnosis
Needle biopsy Malignant Benign Total
Malignant 30 0 30
Benign 01 5 06
Total 31 5 36
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YU LS e col. - Biópsia de lesões
pulmonares por agulha cortante
guiada pela tomografia computa-
dorizada. Rev. Hosp. Clín. Fac.
Med. S. Paulo 57(1):15-18, 2002.
OBJETIVO: Apresentar a expe-
riência inicial de um serviço de radio-
logia, no uso de biópsia de lesões
pulmonares por agulha cortante guiada
por tomografia computadorizada,
avaliando o valor diagnóstico e inci-
dência de complicações.
MÉTODOS: Realizamos análise
retrospectiva de 52 pacientes submeti-
dos à biópsia de lesão pulmonar guia-
da pela tomografia computadorizada.
Analisamos o período de maio de 1997
até maio de 2000. Trinta e cinco paci-
entes eram de sexo masculino e 17 fe-
minino, com idade variando de cinco
a 85 anos (mediana de 62 anos). O ta-
manho das lesões pulmonares variou
de 1,8 a 15 cm (mediana de 5,4 cm).
RESULTADOS: Entre os 52 casos,
51 (98,1%) forneceram material ade-
quado para diagnóstico histopatológico,
com nove diagnósticos (17,3%) de le-
são benigna e 42 (80,8%) de lesão ma-
ligna. Quarenta e quatro (84,6%) obti-
veram diagnósticos específicos a partir
de análise histopatológica, sendo quatro
benignos e 40 malignos. A sensibilida-
de, a especificidade e a acurácia do mé-
todo para lesões malignas foi de 96,8%,
100% e 97,2%, respectivamente. Nove
casos (17,3%) de complicações ocorre-
ram, sendo seis casos (11,5%) de
pneumotórax pequeno, um (1,9%) de
hemoptise, um (1,9%) de hematoma
intrapulmonar e um outro caso (1,9%)
de hematoma na parede torácica. Não
houve complicação que necessitasse de
intervenção posterior.
CONCLUSÃO: As altas sensibili-
dade e especificidade, e o baixo índice
de complicações tornam o método de
biópsia por agulhas cortantes uma fer-
ramenta eficiente e segura para diagnós-
tico de lesões pulmonares. Em nosso
hospital é considerado um procedimen-
to confiável para a avaliação de nódu-
los pulmonares indeterminados.
DESCRITORES: Neoplasia pul-
monar. Tomografia computadoriza-
da. Biópsia por agulha.
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